GST for Indian Clinics: Classify Healthcare, Pharmacy and Other Supplies
Separate healthcare exemption, independent goods sales, registration and input-credit questions using a dated supply-classification record.
Choose a clinic-pharmacy structure by identifying the real supplier, owner of stock, licensed activity and flow of money. One billing screen does not make two businesses one entity, and two invoice series do not create two independent taxpayers. Compare the operational work and professional advice required for each arrangement before configuring invoices, GST details, payment collection and patient access.
Indian doctors and clinic owners considering an in-house dispensary, a connected pharmacy or a separate pharmacy business using shared premises or software.
Four boundaries often get confused: the legal person carrying on the activity, the tax registration, the licensed premises or activity, and the software workspace. They may align, but they are not interchangeable.
A clinic and pharmacy can appear in one application while having different suppliers and financial responsibilities. Conversely, one legal person may use several invoice series or counters. The screen layout alone cannot determine which arrangement exists.
Start by writing the actual names and identifiers on existing contracts, licences, purchase invoices, bank accounts and patient documents. Differences that staff describe as 'just a display name' may require explanation before a new billing configuration is safe to use.
Separate the question of tax treatment from authority to dispense or sell medicines. A GST registration does not establish a drug-sale permission, and a clinical prescription is not evidence that a particular entity supplied the medicine.
Use an accountant and the appropriate licensing adviser to assess the proposed arrangement. The clinic's useful preparation is a factual map, including who owns stock, employs the relevant staff, receives money and bears a refund or recall responsibility.
Within a single genuine entity, a shared ledger may make cash collection and reporting easier. That does not remove the need to distinguish consultation services, independently supplied goods, stock movements and any applicable tax treatments.
Keep a meaningful service and product catalogue. If a clinician recommends a medicine that the patient buys elsewhere, the clinic should not record a sale. If stock is supplied, identify the actual product, quantity and source record rather than deriving the sale from the prescription alone.
The CGST aggregate-turnover definition uses the same-PAN supply position across India. Separate counters or invoice prefixes do not by themselves create separate turnover pools. Current registration conditions still need review for the particular activity mix and states.
Do not treat one entity as permission for universal staff access. Reception, clinicians and dispensing staff may need different information and authority. A person who can receive payment should not automatically be able to alter a signed instruction.
Review the actual availability of dispensing and inventory features before relying on a shared software account. The operational design should reflect the configured capability and authorised roles, not an assumption that every connected module is active.
Source: CBIC: CGST Act, aggregate turnover and registration provisions
A genuinely separate pharmacy arrangement needs a clear supplier identity on its transactions, its own relevant permissions and a documented relationship with the clinic. The details depend on the actual structure; changing a logo or adding a second GST field is not enough.
Identify who purchases and owns each stock batch. If one business purchases stock and another supplies it, the movement and commercial arrangement need appropriate documentation. Do not make a physical shelf transfer disappear as an unrecorded software adjustment.
Map shared costs such as rent, reception, equipment or software. An agreed allocation or service arrangement needs evidence and accounting review. Informal month-end transfers are difficult to explain if nobody can identify what they settle.
Keep patient choice clear. The clinical recommendation and the patient's decision about where to obtain medicines should not be rewritten as proof of a sale to a connected pharmacy. If external supply information comes back, distinguish it from stock the clinic itself issued.
Define the operational handover: what information is shared, for what purpose, who receives it and how corrections are communicated. Separate legal entities should not be treated as one unrestricted clinical record merely because the staff know one another.
Use the map below before choosing an integrated checkout. The person who performs a step may differ from the entity responsible for it. A receptionist collecting money on behalf of another supplier needs an authorised, explainable arrangement.
Give patients documents that identify the relevant supplier and amounts. If a combined statement is used for convenience, it should not obscure the underlying invoices, tax treatment or refund route. Have the proposed document layout reviewed for the arrangement.
Keep clinical corrections and commercial corrections distinct. A medicine instruction can change without proving stock was returned; a refunded item can remain clinically relevant in the patient's history. Each event needs its own record.
Trace a recall or quality concern through the stock owner and supplier records. A clinic that sees a patient for follow-up may still need to coordinate with another entity that supplied the product. A shared dashboard does not settle that responsibility.
On a narrow screen, scroll the table horizontally to read all columns.
| Record or action | Question to settle | Evidence to retain |
|---|---|---|
| Prescription | Who authorised the clinical instruction? | Prescriber and signed version |
| Stock receipt | Which entity acquired the batch? | Purchase and receiving record |
| Patient supply | Which supplier issued the quantity? | Supply record and invoice link |
| Payment | For whose bill was money collected? | Receipt allocation and settlement |
| Return or refund | Who accepts the item and owes the remedy? | Disposition and financial adjustment |
| Shared expense | Which activity benefits and under what arrangement? | Approved allocation and supporting invoice |
Consider a fictional, properly authorised shared-counter arrangement. The clinic's consultation bill is ₹700 and a separate pharmacy's final bill is ₹315. Assume each supplier has already determined its correct tax treatment. The patient owes ₹1,015 in total.
If the patient tenders ₹1,200 in cash, change is ₹185. The collection record should allocate ₹700 to the clinic bill and ₹315 to the pharmacy bill. It should not treat the full ₹1,015 as consultation revenue simply because the clinic counter handled the cash.
The inter-entity settlement must explain where the pharmacy's ₹315 is held and when it is transferred under the agreed process. The accounting entries require professional review; the example demonstrates allocation, not a universal agency or tax treatment.
If the pharmacy later makes an authorised ₹70 refund, its retained amount becomes ₹245 and the patient's net total payment becomes ₹945. The consultation remains ₹700 unless a separate authorised adjustment affects it. Do not cancel or rebuild both bills to accommodate one supplier's refund.
Use the same reasoning with UPI, but include the actual beneficiary account and confirmed transaction evidence. A QR code leading to one entity's account does not establish that another entity has received its allocation.
Reconcile each supplier's balance as well as the shared counter total. A perfect total of ₹1,015 can still hide a ₹100 misallocation between the two businesses.
Compare the real effort of each option: licensing, accounting, stock reconciliation, access control, patient documents, staff training and correction handling. A second entity may clarify responsibilities but also creates additional work. Do not assume it is automatically cheaper or simpler.
Ask the adviser to document why the chosen tax and legal arrangement matches the facts. Avoid structuring paper-only separations solely to make turnover or tax obligations appear smaller. The records should describe how the activity actually operates.
Run a fictional acceptance case from prescription through partial supply, payment and refund. Include a patient who buys elsewhere and a medicine change after the first document was issued. Confirm that neither a sale nor a clinical decision is invented by the connection.
Check the exit path too. If the pharmacy changes software or the relationship ends, each entity should be able to identify its own transactions, outstanding settlements and authorised access. Historical patient copies must remain understandable.
Use the resulting map as the software brief. 'Integrated billing' should mean specific agreed behaviours, such as visible allocation and supplier-specific documents. It should not be a promise that one configuration removes separate professional responsibilities.
In a fictional clinic-pharmacy setup, the shared software prints the clinic name on a refund for stock sold by the separate pharmacy. The total cash movement is correct, but the document attributes the remedy to the wrong supplier. The team corrects the mapping, reviews affected documents and verifies the pharmacy's settlement. This is why a combined cash total and an attractive receipt are insufficient acceptance evidence.
Use these prompts in your clinic’s own notes. Record the result, responsible person and next action for each item.
No. The actual legal and tax arrangement exists independently of the software fields. Configure supplier identities and registrations to match the documented structure, not the other way round.
Do not assume so. The CGST aggregate-turnover concept considers the same-PAN supply position across India. Have the current registration and activity-specific conditions assessed.
Only within an appropriately authorised and reviewed collection arrangement. Preserve each supplier's bill, the actual payment beneficiary, allocation and settlement. A combined total must not hide who supplied what.
No. Tax registration and authority for the actual medicine activity are separate matters. Verify the applicable drug-law and professional requirements for the specific arrangement.
No universal answer follows. Compare the real supplier and licensing position, accounting work, stock ownership, patient access and correction responsibilities with professional advice.
Updated on . This is original operational analysis for a clinic-pharmacy structure discussion. It does not recommend a particular entity, establish a collection agency arrangement or determine GST, drug-licensing or accounting obligations. No independent clinical or legal review is claimed.
Primary Act reproduction accessed 25 October 2026 for the same-PAN aggregate-turnover concept and supplier/registration distinctions. This older reproduction is not treated as a consolidated 2026 law or a universal registration-threshold calculator.
Separate healthcare exemption, independent goods sales, registration and input-credit questions using a dated supply-classification record.
Connect the signed visit, correct bill and confirmed cash or UPI payment without losing prescriptions, pending care or an unpaid balance.
Follow one consultation across test orders, specimens, medicine supply, payment and result review with separate owners and open-work records.
Bring the fictional ₹1,015 two-supplier case to a Bractis discussion. Verify available supplier documents, payment allocation and refund history against the structure approved by your professional advisers.
Request a clinic demo